Dermatology Times

APRIL 25, 2025

Alexandra Golant, MD, discusses how advancements in pediatric atopic dermatitis (AD) treatment, including topical Janus kinase (JAK) inhibitors like ruxolitinib, may reshape guidelines, yet hurdles remain in regulatory approval, safety data, and accessibility. Adoption depends on efficacy, cost, insurance, and caregiver education.

Dermatitis 36

Dermatitis Treatments Therapy Safety 36

Dermatology Times

MARCH 28, 2024

Today officially marks 7 years since the US FDA approved dupilumab for the treatment of atopic dermatitis. Here's a look back at its approval timeline and all it has accomplished in the dermatology world in the time since.

Dermatitis 88

Dermatitis Dermatology Treatments 88

Dermatology Times

JUNE 9, 2024

Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.

Dermatitis 92

Dermatitis 92

The Dermatology Digest

DECEMBER 30, 2024

the Society introduced the SOCS Center for Leadership (CFL) , an educational program designed to develop leaders who will drive the dermatology field forward. Alexis and Kwatra “Seborrheic Dermatitis in Skin of Color” with Drs. The CFL offers leadership education and development through a health equity lens.

Webinar 78

Webinar Education Social Media Dermatology 78

The Dermatology Digest

FEBRUARY 12, 2025

Maybe, according to new research in Dermatology Practical & Conceptual. There is a high prevalence of skin conditions, such as seborrheic dermatitis, melanoma, bullous pemphigoid, and rosacea among people with PD. appeared first on The Dermatology Digest.

Sebum 62

Sebum Tools Rosacea Dermatitis 62

Dermatology Times

MAY 15, 2024

In this month’s Cosmetic Conundrums column, explore what dermatology clinicians need to know about false eyelashes to help prevent infections or contact dermatitis.

Dermatology 74

Dermatology Dermatitis 74

Dermatology Times

JUNE 10, 2024

David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.

Dermatitis 85

Dermatitis 85

Dermatology Times

JUNE 1, 2024

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

Dermatitis 80

Dermatitis Treatments 80

Dermatology Times

MARCH 4, 2024

Raj Chovatiya, MD, PhD, gives a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the last meeting, the AAD has released new guidelines to treat the condition.

Dermatitis 74

Dermatitis Education Dermatology 74

Dermatology Times

APRIL 5, 2024

Mark Lebwohl, MD, emphasizes the importance of considering various factors, including severity of itch and interference with sleep, when determining treatments for patients with atopic dermatitis, even with presentation may not include typical symptoms.

Dermatitis 87

Dermatitis Treatments 87

Dermatology Times

DECEMBER 5, 2023

Zakiya Pressley Rice, MD, took a deep dive into how atopic dermatitis severity and increased rates of grade school absenteeism affect patients with skin of color during a recent Masterclasses in Dermatology meeting.

Dermatitis 78

Dermatitis Dermatology 78

Dermatology Times

MAY 7, 2024

A 5-expert panel delves into atopic dermatitis guidelines and recommendations and recent studies to make note of.

Dermatitis 88

Dermatitis Clinic Treatments 88

Dermatology Times

JUNE 10, 2024

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.

Dermatitis 74

Dermatitis 74

Dermatology Times

DECEMBER 6, 2024

A study using proteome-wide association techniques identified novel protein biomarkers for atopic dermatitis.

Dermatitis 81

Dermatitis 81

Dermatology Times

JUNE 11, 2024

Gil Yosipovitch, MD, addresses the severity of chronic itch and sleep disturbances in patients with atopic dermatitis.

Dermatitis 77

Dermatitis 77

The Dermatology Digest

MARCH 7, 2024

Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, discusses advances in treating kids with atopic dermatitis, psoriasis, vitiligo, alopecia areata, and hemangiomas. Watch Now [the_ad id="7336"] [the_ad id="8980"] The post Welcome to the Golden Age of Pediatric Dermatology appeared first on The Dermatology Digest.

Dermatology 68

Dermatology Dermatitis Therapy 68

The Dermatology Digest

APRIL 2, 2025

A Qin-Zhu-Liang-Xue (QZLX) decoction may help improve the symptoms of atopic dermatitis (AD), according to preclinical and clinical studies. QZLX significantly improved AD symptoms, as indicated by reduced SCORing Atopic Dermatitis (SCORAD) and Dermatology Life Quality Index (DLQI) scores, with no serious adverse effects.

Dermatitis 36

Dermatitis Networking Dermatology Ingredients 36

The Dermatology Digest

DECEMBER 27, 2024

Johnson & Johnson has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic diseases, including atopic dermatitis (AD), from Kaken Pharmaceutical.

Dermatitis 36

Dermatitis Portfolios Pharmaceutical Innovations 36

Dermatology Times

MAY 30, 2024

Raj Chovatiya, MD, PhD, reviews the varying degrees of influence of skin barrier disruption, immune dysregulation, and Malassezia yeast in seborrheic dermatitis.

Dermatitis 74

Dermatitis 74

Dermatology Times

NOVEMBER 12, 2023

What are some of the challenges and triumphs in using biologics for atopic dermatitis? Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.

Dermatitis 87

Dermatitis 87

Dermatology Times

JULY 13, 2024

Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.

Dermatitis 78

Dermatitis Innovations 78

Dermatology Times

DECEMBER 11, 2023

A poster from the 2023 Revolutionizing Atopic Dermatitis Conference revealed a link between AD, impaired oral health, and oral dysbiosis.

Dermatitis 81

Dermatitis 81

Dermatology Times

FEBRUARY 20, 2025

The panelist discusses how understanding the diverse manifestations of atopic dermatitis enables health care providers to develop personalized treatment approaches for optimal patient outcomes.

Dermatitis 70

Dermatitis Treatments 70

The Dermatology Digest

OCTOBER 31, 2024

[link] Patrick Burnett, MD, PhD, Chief Medical Officer of Arcutis Biotherapeutics, reviews new data on the use of topical roflumilast (Zoryve) in scalp and body psoriasis, seborrheic dermatitis, and atopic dermatitis in patients with diverse skin types presented at the 2024 Fall Clinical Dermatology Conference in Las Vegas, NV.

Skin Types 36

Skin Types Dermatitis Office Dermatology 36

Dermatology Times

APRIL 12, 2024

Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives. She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment.

Dermatitis 85

Dermatitis Treatments Safety Management 85

The Dermatology Digest

APRIL 7, 2025

The post Shared-decision Making in AD: Incorporating the Minimal Disease Activity Concept With Vimal Hasmukh Prajapati, MD, FRCPC appeared first on The Dermatology Digest.

Dermatitis 36

Dermatitis Skin Health Dermatology Clinic 36

Dermatology Times

JUNE 11, 2024

Kristine Kucera, PA-C, MPAS, DHS, discusses the atopic dermatitis patient experience alongside one of her patients, Mickey Bryson.

Dermatitis 74

Dermatitis 74

US Dermatologt Partners

FEBRUARY 11, 2025

Dermatology Partners is pleased to welcome Irasema Iris Gipson, MPAS, PA-C to its office in Cushing, Oklahoma. Dermatology Partners, she served as a Physician Assistant in dermatology at OU Health in Oklahoma City. She provides a wide range of dermatologic care to patients of all ages in Payne County and the surrounding areas.

Office 41

Office Dermatology Hospital Dermatitis 41

Dermatology Times

APRIL 2, 2025

Get a glimpse of the cutting-edge atopic dermatitis research, breakthroughs, and insights to be presented at the 7th RAD Annual Meeting, June 6-7, 2025.

Dermatitis 64

Dermatitis 64

Dermatology Times

OCTOBER 3, 2024

Jason Hawkes, MD, MS, emphasized the importance of biologic treatments transforming the management of both prurigo nodularis and atopic dermatitis.

Dermatitis 74

Dermatitis Clinic Management Treatments 74

Dermatology Times

NOVEMBER 10, 2023

A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis.

Dermatitis 78

Dermatitis 78

Dermatology Times

JANUARY 11, 2024

Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.

Dermatitis 74

Dermatitis Innovations Treatments 74

Dermatology Times

APRIL 18, 2024

Researchers noted that further examination and monitoring for headache disorders in patients with atopic dermatitis may be warranted.

Dermatitis 78

Dermatitis 78

Dermatology Times

SEPTEMBER 30, 2023

Colleen Cotton, MD, does a deep dive on pediatric atopic dermatitis and explains the importance of timing and conversations with patients about different treatments.

Dermatitis 78

Dermatitis Treatments 78

Dermatology Times

FEBRUARY 18, 2025

Jonathan Zalevsky, PhD, discusses the unmet needs in atopic dermatitis treatment, the potential of Rezpeg, and the importance of novel therapies.

Dermatology 68

Dermatology Dermatitis Therapy Treatments 68

Dermatology Times

MAY 14, 2024

A 5-expert panel continues their conversation on atopic dermatitis, exploring beyond steroids and addressing unmet needs.

Dermatitis 74

Dermatitis Clinic Treatments 74

Dermatology Times

MAY 21, 2024

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.

Dermatitis 74

Dermatitis Clinic Treatments 74